GANX NASDAQ
Gain Therapeutics, Inc.
1W: -3.9%
1M: -4.5%
3M: -5.5%
YTD: -46.2%
1Y: -6.0%
3Y: -46.7%
5Y: -77.0%
$1.71
-0.01 (-0.58%)
Weekly Expected Move ±7.2%
$1
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-20M
Net Income
-8.1% YoY
$-19M
Free Cash Flow
-2.7% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-268.3%
ROA-159.2%
ROIC1288.8%
Valuation
P/E-3.4
P/B6.5
EV/EBITDA-3.9
Leverage
Debt/Equity0.05
Current Ratio4.36
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z-0.70
Beneish M0.00